|1.||Jo, Seongbong: 1 article (09/2006)|
|2.||Jeong, Ji Hoon: 1 article (09/2006)|
|3.||Kim, Sung Wan: 1 article (09/2006)|
|4.||Kim, Won Jong: 1 article (09/2006)|
|5.||Kim, Yong-Hee: 1 article (09/2006)|
|6.||Christensen, Lane V: 1 article (09/2006)|
|7.||Yockman, James W: 1 article (09/2006)|
09/01/2006 - "Hence, we propose a novel and simple system for the local in vivo application of siRNA through Chol-R9 for cancer therapy."
09/01/2006 - "In this study, we tested the hypothesis that a hydrophobically modified protein transduction domain, cholesteryl oligo-d-arginine (Chol-R9), may stabilize and enhance tumor regression efficacy of the VEGF-targeting siRNA. "
09/01/2006 - "Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma."
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Small Interfering RNA (siRNA)